Richard Weinberger
Family Medicine · Beachwood, OHNPI 1619978517
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 275 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 11.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,459 and has fallen 90.5% since, to $139 in 2023.
Across 275 payments — averaging $15.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$502
- Lilly USA, LLC$464
- AstraZeneca$457
- AbbVie$446
- Novo Nordisk$370
- Johnson & Johnson$271
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,18898%
- Education$702%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 33 | $502 |
| Lilly USA, LLC | 35 | $464 |
| AstraZeneca | 33 | $457 |
| AbbVie(2 entities) | 27 | $446 |
| Novo Nordisk | 22 | $370 |
| Johnson & Johnson | 17 | $271 |
| Amgen(2 entities) | 14 | $220 |
| Amarin Pharma, Inc. | 9 | $157 |
| Boehringer Ingelheim | 8 | $143 |
| Teva Pharmaceuticals USA, Inc. | 8 | $116 |
| Sunovion Pharmaceuticals Inc. | 6 | $112 |
| GSK | 7 | $107 |
| E.r. Squibb & Sons, L.L.C. | 7 | $89 |
| Astellas Pharma US Inc | 5 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $80 |
| Abbott | 4 | $80 |
| Ultragenyx Pharmaceutical Inc. | 3 | $66 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $66 |
| Merck | 4 | $60 |
| Sanofi-aventis U.S. LLC | 3 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Sanofi Pasteur Inc. | 3 | $44 |
| Supernus Pharmaceuticals, Inc. | 2 | $26 |
| Novartis | 2 | $26 |
| Strongbridge US Inc. | 2 | $24 |
| Sanofi | 1 | $23 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $16 |
| Medtronic | 1 | $14 |
How this compares
$4,258 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Beachwood
- Darshana PatelBeachwood$648K
- Lee ResnickBeachwood$20K
- Kwabena OtengSpringdale$2M
- Brian BeesleyColumbus$1.4M
- Thomas GraceFindlay$503K
- Susan RatayAshtabula$379K
- Shannon TrotterSpringfield$348K
- Michael HeileCincinnati$272K
- Bradley EverlyMaumee$266K
- Tricia BedrickCuyahoga Falls$259K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.